The U.S. Food and Drug Administration has approved tirzepatide for chronic weight management. The drug previously was approved for the treatment of type 2 diabetes under the trade name Mounjaro.
PHARMACOLOGY UPDATE
Tirzepatide Injection (Zepbound)
December 15, 2023